This state-of-the-art review and international consensus statement updates prior recommendations for drug-coated balloons and reviews efficacy and safety in in-stent restenosis, de novo small vessel disease, high-bleeding-risk patients, bifurcation lesions, and large vessel disease. There are minimal data that support the use of drug-coated balloons in patients with diabetes mellitus and acute coronary syndromes.

Read the Key Points